Today

Agents

Chat

Arena

Discover

More

App

Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million - SNOA News | Rallies

Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million

SNOA•2026-08-06

Q1 financial metrics

Aug. 6 (Reuters) - Sonoma Pharmaceuticals Q1 EBITDA USD 100 thousand.

Q1 gross profit USD 2.6 million
Q1 revenue USD 6.4 million

Related News

Champion Homes Inc <SKY.N>: UBS raises target price to $115 from $93

SKY•2026-08-06

Elanco Animal Health Incorporated <ELAN.N>: UBS raises target price to $33 from $31

ELAN•2026-08-06

Cencora, Inc. <COR.N>: UBS Raises Target Price to $430 From $412

•

2026-08-06

Treasury yields climb as traders watch Iran talks, wait on jobs report

TLT•2026-08-06

Nasdaq trade halt continues <OST.O> reason not available at 09:39 AM

OST•2026-08-06